Beacon Biosignals raised $11M, bringing its Series B financing to over $97M.
- Amount
- $11M
- Stage
- Series B
- Announced
- 6 April 2026
- Investors
- JSL Health, Palo Santo VC, Kicker Ventures, Samsung Next
- Use of funds
- To further accelerate its mission to transform brain health through scalable, at-home EEG and advanced analytics
- Total raised
- $132M to date
- Checked
- Amount and date checked against the press source